Päivä, Hannu

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

Valkonen, V.-P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimäki, T., Laakso, J., & Laaksonen, R. (2001) · The Lancet

Nitric Oxide and Endothelin EffectsCancer-related gene regulation

Cited by 562

Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin

Schick, B. A., Laaksonen, R., Frohlich, J. J., Päivä, H., Lehtimäki, T., Humphries, K. H., & Côté, H. C. F. (2007) · Clinical Pharmacology & Therapeutics

Mitochondrial Function and PathologyLipoproteins and Cardiovascular Health

Cited by 103

Beyond LDL-C lowering: distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency

Jänis, M. T., Tarasov, K., Ta, H. X., Suoniemi, M., Ekroos, K., Hurme, R., Lehtimäki, T., Päivä, H., Kleber, M. E., März, W., et al. (2013) · Atherosclerosis

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 41